Miami, FLNCT05696613Now EnrollingIRB Ready

Primary Membranous Nephropathy Clinical Trial in Miami, FL

Access cutting-edge primary membranous nephropathy treatment through this clinical trial at a research site in Miami. Study-provided care at no cost to qualified participants.

Sponsored by Cerium Pharmaceuticals, Inc.

Quick Self-Assessment

See if you qualify for this Miami location

Preparing your pre-screening questions...

Expert Care in Miami

Access primary membranous nephropathy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related primary membranous nephropathy treatment provided free

Apply for This Miami Location

Check if you qualify for this primary membranous nephropathy clinical trial in Miami, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Miami

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Miami site if eligible
  4. 4Begin participation

About This Primary Membranous Nephropathy Study in Miami

The goal of the Phase 3a part of this clinical trial is to determine the optimal dose that will be used in the Phase 3b part of this clinical trial. The goal of the Phase 3b part is to assess the efficacy of SNP-ACTH (1-39) Gel relative to rituximab in patients with primary membranous nephropathy (PMN) at month 24.

Sponsor: Cerium Pharmaceuticals, Inc.

Who Can Participate

Inclusion Criteria

Biopsy-proven membranous glomerulonephritis or a diagnosis of MN in patients with Nephrotic Syndrome and a positive anti PLA2R antibody test.
Patients classified to be at a High Risk for progressive loss of kidney function, as defined by Kidney Disease Improving Global Outcomes (KDIGO) 2021-Glomerular Diseases Guideline.
eGFR by Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula ≥40 mL/min/1.73 m\^2
Patients who have had CR or PR in response to immunosuppressive therapy, but then relapsed can participate in the study if it has been more than 3 months since their last dose of high dose glucocorticoids, calcineurin inhibitors or mycophenolate mofetil
Patients who have had CR or PR in response to IS therapy, but then relapsed can participate in the study if it has been more than 6 months since their last dose of chlorambucil or cyclophosphamide
Patients who have had CR or PR in response to immunosuppressive therapy, but then relapsed can p

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Miami?

Yes, this clinical trial (NCT05696613) has an active research site in Miami, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Primary Membranous Nephropathy Treatment Options in Miami, FL

If you're searching for primary membranous nephropathy treatment options in Miami, FL, this clinical trial (NCT05696613) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Miami research site is actively enrolling participants for this clinical trial. You'll receive care from experienced primary membranous nephropathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all primary membranous nephropathy clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Miami, FL

See all rheumatoid arthritis clinical trials recruiting in Miami — not just this study.

Browse Rheumatoid Arthritis Trials in Miami →

Browse More Trials by Condition

Rheumatoid Arthritis TrialsPulmonary Hypertension TrialsNephrotic Syndrome TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Miami?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Miami, FL